The Determinants of CD8 T cell Dysfunction in Oral Cavity Squamous Cell Carcinoma

口腔鳞状细胞癌 CD8 T 细胞功能障碍的决定因素

基本信息

  • 批准号:
    10677361
  • 负责人:
  • 金额:
    $ 3.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-05-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Head and neck cancer, including oral cavity squamous cell carcinoma (OCSCC), is the sixth leading cause of cancer and a major cause of morbidity and mortality. Unfortunately, the five-year survival rate of OCSCC has only slightly improved in the past 30 years. Recently, immune checkpoint inhibition (ICI) therapies have emerged as a promising treatment to improve OCSCC outcomes, yet only 14-22% of OCSCC patients respond to ICI. Thus, delineating the mechanisms of ICI resistance represents an opportunity to identify novel targets that may increase ICI efficacy and improve OCSCC patient survival. CD8 T cells are the primary immune cell type that kills malignant cells during ICI, and their dysfunction may contribute to ICI resistance. During the chronic response to a tumor, CD8 T cells enter an exhausted cell state – a dysfunctional phenotype characterized by decreased ability to lyse target cells. Expression of the transcription factor thymocyte selection-associated HMG box (TOX) is critical for inducing CD8 T cell exhaustion and is enriched in the exhausted CD8 T cell subset within single cell RNA-seq datasets of OCSCC patient tumor samples. The genes that are directly transcriptionally regulated by TOX that promote CD8 T cell dysfunction and may be therapeutically targeted, however, remain poorly defined. In addition to TOX, malignant cell signals may contribute to CD8 T cell dysfunction and ICI resistance. We discovered a hybrid epithelial/mesenchymal (HEM) malignant cell state in OCSCC that localizes to the tumor edge adjacent to CD8 T cells and is associated with exhaustion of these adjacent CD8 T cells. The mechanisms of HEM cells underlying this association are not well understood. The primary hypothesis of this proposal is that CD8 T cell dysfunction in OCSCC is driven by the direct gene targets of TOX in CD8 T cells and by immunosuppressive contact and paracrine signaling from HEM cells. The goal of this proposal is to define mechanisms of CD8 T cell dysfunction that may be targeted to improve ICI through the following Aims: In Aim 1, the direct gene targets of TOX and their role in CD8 T cell dysfunction will be defined in vitro using CD8 T cells isolated from OCSCC samples. In Aim 2, patient-derived CD8 T cells will be co-cultured with patient-matched OCSCC tumor-derived organoids or cancer cell lines expressing a model antigen. In these co-cultures, HEM- specific membrane and secreted proteins will be knocked-down in the malignant cells to determine their role in suppressing CD8 T cells. The proposed research will provide mechanistic insight into CD8 T cell dysfunction in OCSCC, thereby supporting development of new strategies to therapeutically activate CD8 T cells and improve ICI and OCSCC outcomes. Importantly, during this fellowship, I will pursue scientific and clinical activities under the direct mentorship of a comprehensive fellowship advisory committee composed of physician-scientists and experts in cancer and immunology research. My proposed training will be vital to accomplishing my goal of investigating cancer-immune interactions and maturing as an independent, academic physician-scientist.
项目摘要 包括口腔鳞状细胞癌(OCSCC)在内的头颈部癌症是导致口腔癌的第六大原因。 癌症和发病率和死亡率的主要原因。不幸的是,OCSCC的五年生存率 在过去的30年里只略有改善。最近,出现了免疫检查点抑制(ICI)疗法, 作为改善OCSCC结局的有希望的治疗,但只有14-22%的OCSCC患者对ICI有反应。 因此,描绘ICI抗性的机制代表了一个机会,以确定新的目标, 增加ICI功效并改善OCSCC患者存活率。CD 8 T细胞是主要的免疫细胞类型, 在ICI期间杀死恶性细胞,并且它们的功能障碍可能有助于ICI抗性。在慢性 在对肿瘤的应答中,CD 8 T细胞进入耗竭细胞状态-一种功能失调的表型,其特征在于 降低裂解靶细胞的能力。胸腺细胞选择相关转录因子HMG的表达 框(TOX)对于诱导CD 8 T细胞耗竭是关键的,并且在CD 8 T细胞亚群中富集。 OCSCC患者肿瘤样品的单细胞RNA-seq数据集。直接转录的基因 然而,由TOX调节的促进CD 8 T细胞功能障碍并且可能是治疗靶向的, 定义不好。除TOX外,恶性细胞信号可能导致CD 8 T细胞功能障碍和ICI。 阻力我们在口腔鳞状细胞癌中发现了一种上皮/间质混合型(HEM)恶性细胞状态, 与邻近CD 8 T细胞的肿瘤边缘相关,并与这些邻近CD 8 T细胞的耗竭相关。的 HEM细胞在这种关联下的机制还没有很好地理解。这个问题的主要假设是 提出OCSCC中的CD 8 T细胞功能障碍是由CD 8 T细胞中TOX的直接基因靶标驱动的, 通过免疫抑制接触和HEM细胞的旁分泌信号。该提案的目的是定义 通过以下目的可以靶向改善ICI的CD 8 T细胞功能障碍的机制:在目的1中, TOX的直接基因靶点及其在CD 8 T细胞功能障碍中的作用将使用CD 8 T细胞在体外确定 分离自口腔鳞状细胞癌样本。在目标2中,将患者来源的CD 8 T细胞与患者匹配的CD 8 T细胞共培养。 OCSCC肿瘤衍生的类器官或表达模型抗原的癌细胞系。在这些共同培养中, 特异性膜和分泌的蛋白质将在恶性细胞中被敲低,以确定它们在恶性细胞中的作用。 抑制CD 8 T细胞。拟议的研究将提供机制洞察CD 8 T细胞功能障碍, OCSCC,从而支持开发治疗性活化CD 8 T细胞并改善 ICI和OCSCC结果。重要的是,在这个奖学金,我将追求科学和临床活动下, 由医生-科学家组成的综合研究金咨询委员会的直接指导, 癌症和免疫学研究专家。我所建议的训练对我实现 研究癌症与免疫的相互作用,并成为一名独立的学术医生和科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Riley Dalton Zale Mullins其他文献

Riley Dalton Zale Mullins的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Advisory Committees
咨询委员会
  • 批准号:
    7353899
  • 财政年份:
    2006
  • 资助金额:
    $ 3.44万
  • 项目类别:
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
  • 批准号:
    0451289
  • 财政年份:
    2005
  • 资助金额:
    $ 3.44万
  • 项目类别:
    Standard Grant
Advisory Committees
咨询委员会
  • 批准号:
    7557224
  • 财政年份:
  • 资助金额:
    $ 3.44万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7902286
  • 财政年份:
  • 资助金额:
    $ 3.44万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    7691385
  • 财政年份:
  • 资助金额:
    $ 3.44万
  • 项目类别:
Advisory Committees
咨询委员会
  • 批准号:
    8150373
  • 财政年份:
  • 资助金额:
    $ 3.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了